3 resultados para 570
em Brock University, Canada
Resumo:
Coach Richard DesChatelets demonstrates to Brian Kilroy and Kimin Kim. The identity of the demonstration participant is unknown.
Resumo:
Since its discovery nearly a century ago, a-tocopherol (vitamin E) research has been mainly focused on its ability to terminate the cycle of lipid peroxidation in membranes. Nitrobenzoxadiazole fluorescent analogues were made previously to study the intracellular transfer of vitamin E in cells. However, these molecules were reportedly susceptible to photobleaching while under illumination for transfer assays and microscopy. Here is reported the synthesis of a series of fluorescent analogues of vitamin E incorporating the more robust dipyrrometheneboron difluoride fluorophore (BDP-a-Tocs; Aex = 507 nm, Aem = 511 nm). C8-BDP-a-Toc 42c, having an eight-carbon chain between the chromanol and fluorophore, wa<; shown to bind specifically to a-tocopherol transfer protein with a dissociation constant of approximately 100 nM. Another fluorescent analogue of vitamin E with a thienyl derivative of BODIPY that is excited and fluoresces at longer wavelengths (Aex = 561 nm, Aem = 570 nm) is in development.
Resumo:
Basal body temperature (BBT) and thermoeffector thresholds increase following ovulation in
many women. This study investigated if solely central thermoregulatory alterations are responsible.
Seven females in a non-contraceptive group (NCG) were compared with 5 monophasic contraceptive
users (HCG) on separate accounts: pre-ovulation (Trial I; d 2-5) and post-ovulation (Trial 2; 4-8 d
post-positive ovulation) for NCG, and active phase for HCG (d 2-5, d 18-21). During immersion in
28°C water to the axilla, participants exercised for 20-30 min on an underwater ergometer. After
steadily sweating, immersion continued until metabolism increased two-fold due to shivering. Rectal
(Tre) BBT was not different between trials for neither NCG (1: 37.34±0.16°C; 2: 37.35±0.27°C) nor
HCG. At exercise termination, Tre forehead sweating cessation increased (P<0.05) in trial 2
irrespective of group (1: 37.55±0.39°C; 2: 37.90±0,46°C). Tre shivering onset did not increase
(P>0.05) in trial 2 (1: 36.91±0.50°C; 2: 37.07±0,45°C). The widths of the interthreshold zone
increased (P<0.05) in trial 2 (1: 0.64±0.22°C; 2: 0.82±0.37°C) due to the increased sweating threshold
only. HCG cooled quicker (1: -l.15±0,43°C; 2: -1.00±0.50°C) than NCG participants (1: -
0.58±0.22°C; 2: -0.52±O.29°C), and tympanic (Tty) sweat thresholds were significantly (P<0.05)
decreased (1: 34.76±0.54°C; 2: 35.39±0.61°C) versus NCG (l: 35.57±0.77°C; 2: 35.89±1.04°C).
Lastly, Tre and Tty thresholds were significantly different (P